NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: $37.5M Grant for Infectious Disease Management in the US
TL;DR
NETEC's $37.5 million grant offers healthcare facilities a competitive advantage in securing funding for high-consequence infectious disease research and preparedness.
NETEC will distribute $37.5 million to 75 selected healthcare facilities through a formal application process for high-consequence pathogen work.
This initiative strengthens national health security by improving preparedness against dangerous pathogens, creating a safer future for communities.
NETEC's substantial $37.5 million grant represents a major investment in combating special pathogens through expanded laboratory capabilities.
Found this article helpful?
Share it with your network and spread the knowledge!
The grant aims to boost management of high-consequence infectious diseases (HCIDs) and strengthen national health security by expanding special pathogen preparedness across healthcare facilities.
NETEC (National Emerging Special Pathogens Training & Education Center) announced the grant on October 15.
75 healthcare facilities will be selected to receive part of the $37.5 million grant.
Laboratories that do work related to high-consequence pathology and pathogens are urged to call upon their employers to apply for inclusion among the selected facilities.
The grant comes at a time when for-profit entities like Soligenix Inc. are also investing heavily in infectious disease management, highlighting the importance of coordinated public and private efforts.
More information can be found through the NETEC announcement link and additional coverage mentioned in the article, or by visiting BioMedWire's website at https://www.BioMedWire.com.
NETEC is leading the grant initiative, targeting healthcare facilities and laboratories working with high-consequence pathogens, while BioMedWire is providing coverage and communications about the development.
You can receive SMS alerts from BioMedWire by texting 'Biotech' to 888-902-4192 (U.S. Mobile Phones Only) or visit their website for ongoing coverage of biotechnology and biomedical developments.
Curated from InvestorBrandNetwork (IBN)
